Artificial hearts are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
North America is expected to contribute to the largest share in the artificial heart market in the coming years, due to technological advancements as well as improved treatment of cardiac conditions in United States and Canada. Asia Pacific is expected to record substantial demand for artificial heart market during the forecast period, due to the rise in geriatric population in various Asian countries.
In 2019, the market size of Artificial Heart is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Artificial Heart.

This report studies the global market size of Artificial Heart, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Artificial Heart production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation

Market Segment by Product Type
Ventricular Assist Device (VAD)
Total Artificial Heart

Market Segment by Application
Hospitals
Clinics
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Artificial Heart status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Artificial Heart manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Artificial Heart are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025